Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Health Care Trends: Price Transparency Moves to the Forefront

Executive Summary

Price transparency is being touted as one of the chief tools to increase the quality and reduce the costs of health care. Although hospitals and physicians may have put up resistance to the price transparency movement at first, many are now either cooperating or preparing to cooperate with mandates for more disclosure on a variety of issues related to safety, performance, and comparisons with other providers. For the medical device community, the changes have been a reason to gauge how the evolving transformation might alter provider needs, but the whole transparency movement is poised to hit device manufacturers much closer to home than that.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT035169

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel